Breaking News

Global Influenza Viruses Remain Concealed

September 15, 2021 • 4:19 pm CDT
(Precision Vaccinations News)

The World Health Organization (WHO) published Influenza Update N° 402 on September 13, 2021, which disclosed the GISRS laboratories tested more than 282,929 specimens during the last period.

The results showed less than 1% (1,580) were positive for influenza viruses, of which 983 (62.2%) were typed as influenza A and 597 (37.8%) as influenza B.

The WHO reported:

  • In the temperate zones of the southern hemisphere, influenza activity remained at inter-seasonal levels.
  • In the temperate zones of the northern hemisphere, influenza activity remained at inter-seasonal levels. 
  • In the Caribbean and Central American countries, sporadic influenza B/Victoria lineage virus detections were reported from Mexico. 
  • In tropical South America, no influenza detections were reported in this period. 

Separately, the UK's Respiratory Datamart reported no influenza-positive sample detected in week #36. In addition, other indicators for influenza such as hospital admissions and GP influenzalike illness consultation rates remain very low.

The U.S. CDC recommends annual influenza vaccination for most people over the age of 6-months.

Influenza vaccines are manufactured differently, and different preparations have different indications as licensed by the U.S. FDA. The types of influenza vaccines include inactivated influenza vaccines and live attenuated influenza vaccines.

Additionally, two new influenza vaccines have been licensed for use in people aged 65 and older: a quadrivalent high-dose influenza vaccine and a quadrivalent adjuvanted influenza vaccine.

An updated overview of influenza vaccines for the 2021-2022 flu season is published on this webpage.

Medical Review by

Our Trust Standards: Medical Advisory Committee

Share